Vitamin D: A fountain of youth in gene regulation

Vitamin D: Oxidative Stress, Immunity, and Aging

Volumn , Issue , 2012, Pages 3-36

  Jurutka, Peter W ^a,b   Whitfield, G Kerr ^b   Forster, Ryan ^b   Batie, Shane ^a   Lee, Jamie ^a   Haussler, Mark R ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926648448     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13714     Document Type: Chapter

References (188)

1. 3 produced by cultured alveolar macrophages in sarcoidosis. J. Clin. Endocrinol. Metab. 60:960-966.
2. Amling, M., M. Priemel, T. Holzmann, K. Chapin, J.M. Rueger, R. Baron, and M.B. Demay. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-4987.
3. An, B.S., L.E. Tavera-Mendoza, V. Dimitrov, X. Wang, M.R. Calderon, H.J. Wang, and J.H. White. 2010. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol. 30:4890-4900.
4. Araya, Z. and K. Wikvall. 1999. 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochem. Biophys. Acta. 1438:47-54.
5. Arriagada, G., R. Paredes, J. Olate, A. van Wijnen, J.B. Lian, G.S. Stein, J.L. Stein, S. Onate, and M. Montecino. 2007. Phosphorylation at serine 208 of the 1alpha,25-dihydroxy Vitamin D3 receptor modulates the interaction with transcriptional coactivators. J. Steroid Biochem. Mol. Biol. 103:425-429.
6. Audo, I., S.R. Darjatmoko, C.L. Schlamp, J.M. Lokken, M.J. Lindstrom, D.M. Albert, and R.W. Nickells. 2003. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis. Sci. 44:4192-4199.
7. Barletta, F., L.P. Freedman, and S. Christakos. 2002. Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol. Endocrinol. 16:301-314.
8. Barthel, T.K., D.R. Mathern, G.K. Whitfield, C.A. Haussler, H.A.T. Hopper, J.C. Hsieh, S.A. Slater, G. Hsieh, M. Kaczmarska, P.W. Jurutka et al. 2007. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J. Steroid Biochem. Mol. Biol. 103:381-388.
9. Bartik, L., G.K. Whitfield, M. Kaczmarska, C.L. Lowmiller, E.W. Moffet, J.K. Furmick, Z. Hernandez, C.A. Haussler, M.R. Haussler, and P.W. Jurutka. 2010. Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J. Nutr. Biochem. 21:1153-1161.
10. Bartik, L., G.K. Whitfield, M.J. Kaczmarska, T.L. Archuleta, C.A. Haussler, M.R. Haussler, and P.W. Jurutka. 2007. Discovery of nutritionally-derived novel ligands of the vitamin D receptor: Curcumin and tocotrienols. Paper presented at The Endocrine Society (Toronto, ON, Canada).
11. Barwick, J.L., L.C. Quattrochi, A.S. Mills, C. Potenza, R.H. Tukey, and P.S. Guzelian. 1996. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol. Pharmacol. 50:10-16.
12. Batie, S., J.H. Lee, M.R. Haussler, and P.W. Jurutka. 2011. Nutritional crosstalk between resveratrol and vitamin D signaling is mediated by the vitamin D receptor. Proceedings of the Arizona-Nevada Academy of Science 46:32.
13. Baur, J.A. 2010. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 131:261-269.
14. Ben-Dov, I.Z., H. Galitzer, V. Lavi-Moshayoff, R. Goetz, M. Kuro-o, M. Mohammadi, R. Sirkis, T. Naveh-Many, and J. Silver. 2007. The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117:4003-4008.
15. Bergwitz, C., and H. Juppner. 2010. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu. Rev. Med. 61:91-104.
16. Bettoun, D.J., T.P. Burris, K.A. Houck, D.W. Buck, II, K.R. Stayrook, B. Khalifa, J. Lu, W.W. Chin, and S. Nagpal. 2003. Retinoid X Receptor Is a Nonsilent Major Contributor to Vitamin D Receptor-Mediated Transcriptional Activation. Mol. Endocrinol. 17:2320-2328.
17. Bianco, S.D., J.B. Peng, H. Takanaga, Y. Suzuki, A. Crescenzi, C.H. Kos, L. Zhuang, M.R. Freeman, C.H. Gouveia, J. Wu et al. 2007. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J. Bone Miner. Res. 22:274-285.
18. Bikle, D. 2009. Extrarenal synthesis of 1,25-dihydroxyvitamin D and its health implications. Clin. Rev. Bone Miner. Metab. 7:114-125.
19. 3. J. Invest. Dermatol. 119:1109-1113.
20. Bikle, D.D., Y. Oda, and Z. Xie. 2004. Calcium and 1,25(OH)2D: Interacting drivers of epidermal differentiation. J. Steroid Biochem. Mol. Biol. 89-90:355-360.
21. Bikle, D.D., and S. Pillai. 1993. Vitamin D, calcium and epidermal differentiation. Endocr. Rev. 14:3-19.
22. Bishop, K.A., M.B. Meyer, and J.W. Pike. 2009. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol. Endocrinol. 23:2095-2110.
23. 3 in chick parathyroid glands. Proc. Natl. Acad. Sci. USA 72:4871-4875.
24. 3. J. Biol. Chem. 268:27371-27380.
25. Cardus, A., S. Panizo, M. Encinas, X. Dolcet, C. Gallego, M. Aldea, E. Fernandez, and J.M. Valdivielso. 2009. 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 204:85-89.
26. Cha, S.K., M.C. Hu, H. Kurosu, M. Kuro-o, O. Moe, and C.L. Huang. 2009. Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol. Pharmacol. 76:38-46.
27. Chawla, A., J.J. Repa, R.M. Evans, and D.J. Mangelsdorf. 2001. Nuclear receptors and lipid physiology: Opening the X-files. Science 294:1866-1870.
28. Chen, C.D., S. Podvin, E. Gillespie, S.E. Leeman, and C.R. Abraham. 2007. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc. Natl. Acad. Sci. USA 104:19796-19801.
29. Cheng, J.B., D.L. Motola, D.J. Mangelsdorf, and D.W. Russell. 2003. De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 278:38084-38093.
30. Clemens, T.L., X.Y. Zhou, J.W. Pike, M.R. Haussler, and R.S. Sloviter. 1985. 1,25-Dihydroxyvitamin D receptor and vitamin D-dependent calcium binding protein in rat brain: Comparative immunocytochemical localization. In Vitamin D: Chemical, Biochemiscal and Clinical Update, ed. A.W. Norman, K. Schaefer, H.-G. Grigoleit, and D.V. Herrath, 95-96. Berlin, Germany: Walter de Gruyter.
31. Cohen-Lahav, M., S. Shany, D. Tobvin, C. Chaimovitz, and A. Douvdevani. 2006. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transplant 21:889-897.
32. 3-receptor heterodimers with high affinity. Mol. Cell. Endocrinol. 113:89-98.
33. de Urquiza, A.M., S. Liu, M. Sjoberg, R.H. Zetterstrom, W. Griffiths, J. Sjovall, and T. Perlmann. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-2144.
34. 3. Proc. Natl. Acad. Sci. USA 89:8097-8101.
35. Donmez, G., D. Wang, D.E. Cohen, and L. Guarente. 2010. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell. 142:320-332.
36. 3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp. Cell. Res. 274:323-333.
37. Drocourt, L., J.C. Ourlin, J.M. Pascussi, P. Maurel, and M.J. Vilarem. 2002. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem. 277:25125-25132.
38. Dussault, I., and B.M. Forman. 2000. Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors. Prostaglandins Other Lipid Mediat. 62:1-13.
39. Echchgadda, I., C.S. Song, A.K. Roy, and B. Chatterjee. 2004. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol. 65:720-729.
40. Eelen, G., C. Gysemans, L. Verlinden, R. Gijsbers, I. Beullens, M. Van Camp, J. Paik, R. DePinho, R. Bouillon, and A. Verstuyf. 2009. Induction of FOXO3a by 1,25D in MC3T3E1 cells mediates resistance to oxidative stress. Abstracts from the 14th Workshop on Vitamin D; Brugge, Belgium, October 4-8, 2009, 60.
41. Egan, J.B., P.A. Thompson, M.V. Vitanov, L. Bartik, E.T. Jacobs, M.R. Haussler, E.W. Gerner, and P.W. Jurutka. 2010. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol. Carcinog. 49:337-352.
42. Egan, M.E., M. Pearson, S.A. Weiner, V. Rajendran, D. Rubin, J. Glockner-Pagel, S. Canny, K. Du, G.L., Lukacs, and M.J. Caplan. 2004. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304:600-602.
43. Ellison, T.I., M.K. Smith, A.C. Gilliam, and P.N. MacDonald. 2008. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol. 128:2508-2517.
44. Eloranta, J.J., Z.M. Zair, C. Hiller, S. Hausler, B. Stieger, and G.A. Kullak-Ublick. 2009. Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Mol. Pharmacol. 76:1062-1071.
45. 3-mediated transcriptional repression. Mol. Endocrinol. 10:672-681.
46. Farrow, E.G., S.I. Davis, L.M. Ward, L.J. Summers, J.S. Bubbear, R. Keen, T.C. Stamp, L.R. Baker, L.F. Bonewald, and K.E. White. 2009. Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets. Bone 44:287-294.
47. Forster, R.E., P.W. Jurutka, J.C. Hsieh, C.A. Haussler, C.L. Lowmiller, I. Kaneko, M.R. Haussler, and G. Kerr Whitfield. 2011. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem. Biophys. Res. Commun. 414:557-562.
48. Fretz, J.A., L.A. Zella, S. Kim, N.K. Shevde, and J.W. Pike. 2006. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol. Endocrinol. 20:2215-2230.
49. Fukumoto, S. 2010. FGF23: Phosphate Metabolism and Beyond. IBMS BoneKEy 7:268-278.
50. Garland, C., R.B. Shekelle, E. Barrett-Connor, M.H. Criqui, A.H. Rossof, and O. Paul. 1985. Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet 1:307-309.
51. Gill, R.K., and S. Christakos. 1993. Identification of sequence elements in mouse calbindin-D28K gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. Proc. Natl. Acad. Sci. USA 90:2984-2988.
52. 3. FASEB J 19:1067-1077.
53. Goodwin, B., M.R. Redinbo, and S.A. Kliewer. 2002. Regulation of CYP3A gene transcription by the pregnane X receptor. Annu. Rev. Pharmacol. Toxicol. 42:1-23.
54. Guilliams, T.G. 2004. Homocysteine-A risk factor for vascular diseases: Guidelines for the clinical practice. JANA 7:11-24.
55. Guo, G.L., G. Lambert, M. Negishi, J.M. Ward, H.B. Brewer, Jr., Kliewer, F.J. Gonzalez, and C.J. Sinal. 2003. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278:45062-45071.
56. Hamada, K., A. Umemoto, A. Kajikawa, M.J. Seraj, and Y. Monden. 1994. In vitro formation of DNA adducts with bile acids. Carcinogenesis 15:1911-1915.
57. Haussler, M.R., C.A. Haussler, L. Bartik, G.K. Whitfield, J.C. Hsieh, S. Slater, and P.W. Jurutka. 2008. Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 66: S98-112.
58. Haussler, M.R., C.A. Haussler, G.K. Whitfield, J.C. Hsieh, P.D. Thompson, T.K. Barthel, L. Bartik, J.B., Egan, Y. Wu, J.L. Kubicek et al. 2010. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. J. Steroid Biochem. Mol. Biol. 121:88-97.
59. Haussler, M.R., P.W. Jurutka, M. Mizwicki, and A.W. Norman. 2011. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)vitamin D: Genomic and nongenomic mechanisms. Best Pract. Res. Clin. En. 25:543-559.
60. Haussler, M.R., G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, S.H. Selznick, C.E. Dominguez, and P.W. Jurutka. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:325-349.
61. Hayes, D.P. 2011. Resveratrol and vitamin D: Significant potential interpretative problems arising from their mutual processes, interactions and effects. Med. Hypotheses 77:765-772.
62. 3 modulates phosphorylation of serine 205 in the human vitamin D receptor: Site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry (Mosc) 33:4300-4311.
63. 3 downregulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter. J. Biol. Chem. 279:46406-46414.
64. Hoerer, S., A. Schmid, A. Heckel, R.M. Budzinski, and H. Nar. 2003. Crystal Structure of the Human Liver X Receptor β Ligand-binding Domain in Complex with a Synthetic Agonist. J. Mol. Biol. 334:853-861.
65. Honkakoski, P., T. Sueyoshi, and M. Negishi. 2003. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35:172-182.
66. Hsieh, J.-C., G.K. Whitfield, P.W. Jurutka, C.A. Haussler, M.L. Thatcher, P.D. Thompson, H.T.L. Dang, M.A. Galligan, A.K. Oza, and M.R. Haussler. 2003. Two basic amino acids C-terminal of the P-box specify functional binding of the vitamin D receptor to its rat osteocalcin DNA responsive element. Endocrinology 144:5065-5080.
67. Ichikawa, S., E.A. Imel, M.L. Kreiter, X. Yu, D.S. Mackenzie, A.H. Sorenson, R. Goetz, M. Mohammadi, K.E. White, and M.J. Econs. 2007. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117:2684-2691.
68. Ito, M., Y. Sakai, M. Furumoto, H. Segawa, S. Haito, S. Yamanaka, R. Nakamura, M. Kuwahata, and K. Miyamoto. 2005. Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am. J. Physiol. Endocrinol. Metab. 288: E1101-1109.
69. Jin, C.H., S.A. Kerner, M.H. Hong, and J.W. Pike. 1996. Transcriptional activation and dimerization functions in the human vitamin D receptor. Mol. Endocrinol. 10:945-957.
70. Johnson, J.J., and H. Mukhtar. 2007. Curcumin for chemoprevention of colon cancer. Cancer Lett. 255:170-181.
71. Juppner, H., M. Wolf, and I.B. Salusky. 2010. FGF-23: More than a regulator of renal phosphate handling? J. Bone Miner. Res. 25:2091-2097.
72. Jurutka, P.W., L. Bartik, G.K. Whitfield, D.R. Mathern, T.K. Barthel, M. Gurevich, J.C. Hsieh, M. Kaczmarska, C.A. Haussler, and M.R. Haussler. 2007. Vitamin D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J. Bone Miner. Res. 22 Suppl 2, V2-10.
73. Jurutka, P.W., J.-C. Hsieh, P.N. MacDonald, C.M. Terpening, C.A. Haussler, M.R. Haussler, and G.K. Whitfield 1993. Phosphorylation of serine 208 in the human vitamin D receptor: The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J. Biol. Chem. 268:6791-6799.
74. Jurutka, P.W., J.-C. Hsieh, S. Nakajima, C.A. Haussler, G.K. Whitfield, and M.R. Haussler. 1996. Human vitamin D receptor phosphorylation by casein kinase II at ser-208 potentiates transcriptional activation. Proc. Natl. Acad. Sci. USA 93:3519-3524.
75. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding and interaction with basal transcription factor IIB, in vitro. J. Biol. Chem. 272:14592-14599.
76. Jurutka, P.W., P.N. MacDonald, S. Nakajima, J.-C. Hsieh, P.D. Thompson, G.K. Whitfield, M.A. Galligan, C.A. Haussler, and M.R. Haussler. 2002. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J. Cell. Biochem. 85:435-457.
77. Jurutka, P.W., G.K. Whitfield, J.-C. Hsieh, P.D. Thompson, C.A. Haussler, and M.R. Haussler. 2001. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord. 2:203-216.
78. Kallay, E., P. Pietschmann, S. Toyokuni, E. Bajna, P. Hahn, K. Mazzucco, C. Bieglmayer, S. Kato, and H.S. Cross. 2001. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429-1435.
79. Kalueff, A.V., T. Keisala, A. Minasyan, M. Kuuslahti, S. Miettinen, and P. Tuohimaa. 2006. Behavioural anomalies in mice evoked by “Tokyo” disruption of the Vitamin D receptor gene. Neurosci. Res. 54:254-260.
80. 3. Biochem. J. (Pt 3) 343:705-712.
81. Keisala, T., A. Minasyan, Y.R. Lou, J. Zou, A.V. Kalueff, I. Pyykko, and P. Tuohimaa. 2009. Premature aging in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 115:91-97.
82. 3. Proc. Natl. Acad. Sci. USA 86:4455-4459.
83. Kikuchi, R., S. Sobue, M. Murakami, H. Ito, A. Kimura, T. Iwasaki, S. Shibayama, A. Takagi, T. Kojima, M. Suzuki et al. 2007. Mechanism of vitamin D3-induced transcription of phospholipase D1 in HaCat human keratinocytes. FEBS Lett. 581:1800-1804.
84. Kim, M.S., T. Kondo, I. Takada, M.Y. Youn, Y. Yamamoto, S. Takahashi, T. Matsumoto, S. Fujiyama, Y. Shirode, I. Yamaoka et al. 2009. DNA demethylation in hormone-induced transcriptional derepression. Nature 461:1007-1012.
85. Kim, S., M. Yamazaki, N.K. Shevde, and J.W. Pike. 2007. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol. Endocrinol. 21:197-214.
86. Kim, S., M. Yamazaki, L.A. Zella, N.K. Shevde, and J.W. Pike. 2006. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 26:6469-6486.
87. 3 augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem. Biophys. Res. Commun. 290:650-655.
88. Kliewer, S.A., J.T. Moore, L. Wade, J.L. Staudinger, M.A. Watson, S.A. Jones, D.D. McKee, B.B. Oliver, T.M. Willson, R.H. Zetterstrom et al. 1998. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:73-82.
89. 3 upregulates FGF23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest Liver Physiol. 289: G1036-G1042.
90. Koszewski, N.J., S. Ashok, and J. Russell. 1999. Turning a negative into a positive: Vitamin D receptor interactions with the avian parathyroid hormone response element. Mol. Endocrinol. 13:455-465.
91. Kozoni, V., G. Tsioulias, S. Shiff, and B. Rigas. 2000. The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: Differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis 21:999-1005.
92. 3, 10. Abstracts from the 14th Workshop on Vitamin D. Brugge, Belgium, October 4-8, 2009.
93. Kuro-o, M. 2010. Klotho. Pflugers Arch. 459:333-343.
94. Kuro-o, M., Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, T. Utsugi, Y. Ohyama, M. Kurabayashi, T. Kaname, E. Kume et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51.
95. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M.G. Rosenfeld, and C.K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a corepressor. Nature 377:451-454.
96. Lee, S., D.K. Lee, E. Choi, and J.W. Lee. 2005. Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Mol. Endocrinol. 19:399-408.
97. Li, Y.C., A.E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M. B. Demay. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94:9831-9835.
98. Lian, J.B., V. Shalhoub, F. Aslam, B. Frenkel, J. Green, M. Hamrah, G.S. Stein, and J.L. Stein. 1997. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D downregulates osteocalcin gene expression. Endocrinology 138:2117-2127.
99. Lin, M., and M. Beal. 2003. The oxidative damage theory of aging. Clin. Neurosci. Res. 2:305-315.
100. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:142-153.
101. Liu, P.T., S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken et al. 2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
102. Liu, S., W. Tang, J. Zhou, J.R. Stubbs, Q. Luo, M. Pi, and L.D. Quarles. 2006b. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17:1305-1315.
103. 3 receptor. Mol. Endocrinol. 10:206-215.
104. Lu, T.T., J.J. Repa, and D.J. Mangelsdorf. 2001. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol. Chem. 276:37735-37738.
105. Maglich, J.M., C.M. Stoltz, B. Goodwin, D. Hawkins-Brown, J.T. Moore, and S.A. Kliewer. 2002. Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 62:638-646.
106. Makishima, M., T.T. Lu, W. Xie, G.K. Whitfield, H. Domoto, R.M. Evans, M.R. Haussler, and D.J. Mangelsdorf. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316.
107. Malloy, P.J., L. Peng, J. Wang, and D. Feldman. 2009. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 150:1580-1587.
108. Malloy, P.J., R. Xu, L. Peng, P.A. Clark, and D. Feldman. 2002. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol. Endocrinol. 16:2538-2546.
109. Martin, A., S. Liu, V. David, H. Li, A. Karydis, J.Q. Feng, and L.D. Quarles. 2011. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J 25:2551-2562.
110. Martz, E. 2002. Protein explorer: Easy yet powerful macromolecular visualization. Trends Biochem. Sci. 27:107-109.
111. Masuda, S., V. Byford, A. Arabian, Y. Sakai, M.B. Demay, R. St-Arnaud, and G. Jones. 2005. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology 146:825-834.
112. Masuyama, H., C.M. Brownfield, R. St-Arnaud, and P.N. MacDonald. 1997. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 11:1507-1517.
113. Matsumura, Y., H. Aizawa, T. Shiraki-Iida, R. Nagai, M. Kuro-o, and Y. Nabeshima. 1998. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem. Biophys. Res. Commun. 242:626-630.
114. McKenna, N.J., and B.W. O’Malley. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474.
115. Meyer, M.B., P.D. Goetsch, and J.W. Pike. 2012. VDR/RXR and TCF4/beta-Catenin Cistromes in Colonic Cells of Colorectal Tumor Origin: Impact on c-FOS and c-MYC Gene Expression. Mol. Endocrinol. 26:37-51.
116. Meyer, M.B., M. Watanuki, S. Kim, N.K. Shevde, and J.W. Pike. 2006. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 20:1447-1461.
117. Miedlich, S.U., E.D. Zhu, Y. Sabbagh, and M.B. Demay. 2010. The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice. Endocrinology 151:4607-4612.
118. Milat, F., and K.W. Ng. 2009. Is Wnt signalling the final common pathway leading to bone formation? Mol. Cell. Endocrinol. 310:52-62.
119. Moore, L.B., J.M. Maglich, D.D. McKee, B. Wisely, T.M. Willson, S.A. Kliewer, M.H. Lambert, and J.T. Moore. 2002. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 16:977-986.
120. Mora, J.R., M. Iwata, and U.H. von Andrian. 2008. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat. Rev. Immunol. 685-698.
121. Mordan-McCombs, S., M. Valrance, G. Zinser, M., Tenniswood, and J. Welsh. 2007. Calcium, vitamin D and the vitamin D receptor: Impact on prostate and breast cancer in preclinical models. Nutr. Rev. 65: S131-133.
122. Moreno, J., A.V. Krishnan, S. Swami, L. Nonn, D.M. Peehl, and D. Feldman. 2005. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 65:7917-7925.
123. 3 in intact animals. Endocrinology 140:2224-2231.
124. Nagengast, F.M., M.J. Grubben, and I.P. van Munster. 1995. Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer 31A: 1067-1070.
125. Nishikawa, J., M. Kitaura, M. Matsumoto, M. Imagawa, and T. Nishihara. 1994. Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res. 22:2902-2907.
126. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 87:9995-9999.
127. Norman, A.W., J.B. Frankel, A.M. Heldt, and G.M. Grodsky. 1980. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825.
128. 3 24-hydroxylase gene. J. Biol. Chem. 269:10545-10550.
129. Ohyama, Y., K. Ozono, M. Uchida, T. Shinki, S. Kato, T. Suda, O. Yamamoto, M. Noshiro, and Y. Kato. 1994b. Identification of a vitamin D-responsive element in the 5′-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J. Biol. Chem. 269:10545-10550.
130. Omdahl, J.L., H.A. Morris, and B.K. May. 2002. Hydroxylase enzymes of the vitamin D pathway: Expression, function, and regulation. Annu. Rev. Nutr. 22:139-166.
131. Oury, F., G. Sumara, O. Sumara, M. Ferron, H. Chang, C.E. Smith, L. Hermo, S. Suarez, B.L. Roth, P. Ducy et al. 2011. Endocrine regulation of male fertility by the skeleton. Cell 144:796-809.
132. Parks, D.J., S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore et al. 1999. Bile acids: Natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
133. 3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. J. Bone Miner. Res. 17:2196-2205.
134. Peng, L., P.J. Malloy, and D. Feldman. 2004. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol. Endocrinol. 18:1109-1119.
135. Perwad, F., M.Y. Zhang, H.S. Tenenhouse, and A.A. Portale. 2007. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am. J. Physiol. Renal Physiol. 293: F1577-1583.
136. 3 and its receptor. J. Steroid Biochem. Mol. Biol. 103:389-395.
137. Quarles, L.D. 2008. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 118:3820-3828.
138. Quelo, I., I. Machuca, and P. Jurdic. 1998. Identification of a vitamin D response element in the proximal promoter of the chicken carbonic anhydrase II gene. J. Biol. Chem. 273:10638-10646.
139. Rachez, C., M. Gamble, C.P. Chang, G.B. Atkins, M.A. Lazar, and L.P. Freedman. 2000. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell. Biol. 20:2718-2726.
140. Raghuwanshi, A., S.S. Joshi, and S. Christakos 2008. Vitamin D and multiple sclerosis. J. Cell. Biochem. 105:338-343.
141. Ramagopalan, S.V., N.J. Maugeri, L. Handunnetthi, M.R. Lincoln, S.M. Orton, D.A. Dyment, G.C. Deluca, B.M. Herrera, M.J. Chao, A.D. Sadovnick et al. 2009. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics 5: e1000369.
142. Razzaque, M.S. 2009. The FGF23-Klotho axis: Endocrine regulation of phosphate homeostasis. Nat. Rev. Endocrinol. 5:611-619.
143. Rochel, N., F. Ciesielski, J. Godet, E. Moman, M. Roessle, C. Peluso-Iltis, M. Moulin, M. Haertlein, P. Callow, Y. Mely et al. 2011. Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol. 18:564-570.
144. Rochel, N., J.M. Wurtz, A. Mitschler, B. Klaholz, and D. Moras. 2000. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:173-179.
145. Saeki, M., K. Kurose, M., Tohkin, and R. Hasegawa 2008. Identification of the functional vitamin D response elements in the human MDR1 gene. Biochem. Pharmacol. 76:531-542.
146. Sakai, Y., J. Kishimoto, and M.B. Demay 2001. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J. Clin. Invest. 107:961-966.
147. 3. J. Biol. Chem. 284:8073-8082.
148. Seshadri, S., A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D’Agostino, P.W. Wilson, and P.A. Wolf. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N. Engl. J. Med. 346:476-483.
149. Shimada, T., H. Hasegawa, Y. Yamazaki, T. Muto, R. Hino, Y. Takeuchi, T. Fujita, K. Nakahara, S. Fukumoto, and T. Yamashita. 2004a. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19:429-435.
150. Shimada, T., M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, T. Fujita, S. Fukumoto, K. Tomizuka, and T. Yamashita. 2004b. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113:561-568.
151. 3 induces CCR10 expression in terminally differentiating human B cells. J. Immunol. 180:2786-2795.
152. Sidelnikov, E., R.M. Bostick, W.D. Flanders, Q. Long, V. Fedirko, A. Shaukat, C.R. Daniel, and R.E. Rutherford. 2010. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol. Biomarkers Prev. 19:1022-1032.
153. Sroga G.E., L. Karim, W. Colon, and D. Vashishith. 2011. Biochemical characterization of Major bone-matrix proteins using nano-scale size bone samples and proteomics methodology. Mol. cell Proteomics 10:MIID.006718.
154. St-Arnaud, R. 2010. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J. Steroid Biochem. Mol. Biol. 121:254-256.
155. Staal, A., A.J. van Wijnen, J.C. Birkenhäger, H.A.P. Pols, J. Prahl, H. DeLuca, M.-P. Gaub, J.B. Lian, G.S. Stein, J.P.T.M. van Leeuwen et al. 1996. Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements for the osteocalcin and osteopontin genes. Mol. Endocrinol. 10:1444-1456.
156. Staudinger, J.L., B. Goodwin, S.A. Jones, D. Hawkins-Brown, K.I. MacKenzie, A. LaTour, Y. Liu, C.D. Klaassen, K.K. Brown, J. Reinhard et al. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98:3369-3374.
157. Stubbs, J.R., S. Liu, W. Tang, J. Zhou, Y. Wang, X. Yao, and L.D. Quarles. 2007. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J. Am. Soc. Nephrol. 18:2116-2124.
158. 3. Identification of a vitamin D-responsive element in the human NAPi-3 gene. J. Biol. Chem. 273:14575-14581.
159. Terpening, C.M., C.A. Haussler, P.W. Jurutka, M.A. Galligan, B.S. Komm, and M.R. Haussler. 1991. The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation. Mol. Endocrinol. 5:373-385.
160. Thompson, E.B., and R. Kumar. 2003. DNA binding of nuclear hormone receptors influences their structure and function. Biochem. Biophys. Res. Commun. 306:1-4.
161. Thompson, P.D., P.W. Jurutka, G.K. Whitfield, S.M. Myskowski, K.R. Eichhorst, C.E. Dominguez, C.A. Haussler, and M.R. Haussler. 2002a. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem. Biophys. Res. Commun. 299:730-738.
162. Thompson, P.D., P.W. Jurutka, G.K. Whitfield, S.M. Myskowski, K.R. Eichhorst, C. Encinas Dominguez, C.A. Haussler, and M.R. Haussler. 2002b. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem. Biophys. Res. Commun. 299:730-738.
163. Thompson, P.D., L.S. Remus, J.-C. Hsieh, P.W. Jurutka, G.K. Whitfield, M.A. Galligan, C. Encinas Dominguez, C.A. Haussler, and M.R. Haussler. 2001. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J. Mol. Endocrinol. 27:211-227.
164. 3. Mol. Pharmacol. 60:1399-1406.
165. Thurston, R.D., C.B. Larmonier, P.M. Majewski, R. Ramalingam, M. Midura-Kiela, D. Laubitz, A. Vandewalle, D.G. Besselsen, M. Muhlbauer, C. Jobin et al. 2010. Tumor necrosis factor and interferon-gamma downregulate Klotho in mice with colitis. Gastroenterology 138:1384-1394, 1394, 1381-1382.
166. Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., and Nabeshima, Y. 2003. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17:2393-2403.
167. van Den Bemd, G.J., M. Jhamai, A. Staal, A.J. van Wijnen, J.B. Lian, G.S. Stein, H.A. Pols, and J.P. van Leeuwen. 2002. A central dinucleotide within vitamin D response elements modulates DNA binding and transactivation by the vitamin D receptor in cellular response to natural and synthetic ligands. J. Biol. Chem. 277:14539-14546.
168. 3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 285:2227-2231.
169. 3 target genes. Mol. Endocrinol. 19:2685-2695.
170. 3 in human leukemia HL60 cells through a vitamin D response element in the 5′-flanking region. Oncogene 25:7078-7085.
171. 3) and is required for optimal cell differentiation. Exp. Cell. Res. 313:3034-3045.
172. Wang, Y. and Z. Sun. 2009. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54:810-817.
173. Warnmark, A., E. Treuter, A. Wright, and J.A. Gustafsson. 2003. Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation. Mol. Endocrinol. 17:1901-1909.
174. Watkins, R.E., J.M. Maglich, L.B. Moore, G.B. Wisely, S.M. Noble, P.R. Davis-Searles, M.H. Lambert, S.A. Kliewer, and M.R. Redinbo. 2003. 2.1 A crystal structure of human PXR in complex with the St. John’s wort compound hyperforin. Biochemistry (Mosc) 42:1430-1438.
175. Watkins, R.E., G.B. Wisely, L.B. Moore, J.L. Collins, M.H. Lambert, S.P. Williams, T.M. Willson, S.A. Kliewer, and M.R. Redinbo. 2001. The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity. Science 292:2329-2333.
176. 3 in chicken parathyroid glands. Arch. Biochem. Biophys. 183:168-175.
177. Weissen-Plenz, G., Y. Nitschke, and F. Rutsch. 2008. Mechanisms of arterial calcification: Spotlight on the inhibitors. Adv. Clin. Chem. 46:263-293.
178. Whitfield, G.K., P.W. Jurutka, C.A. Haussler, J.C. Hsieh, T.K. Barthel, E.T. Jacobs, C. Encinas Dominguez, M.L. Thatcher, and M.R. Haussler. 2005. Nuclear vitamin D receptor: Structure-function, molecular control of gene transcription, and novel bioactions. In Vitamin D, ed. D. Feldman, J.W. Pike, and F.H. Glorieux, 219-261. Oxford, U.K.: Elsevier Academic Press.
179. 3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol. Endocrinol. 10:1617-1631.
180. Xie, W., A. Radominska-Pandya, Y. Shi, C.M. Simon, M.C. Nelson, E.S. Ong, D.J. Waxman, and R.M. Evans. 2001. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. USA 98:3375-3380.
181. 3. Proc. Natl. Acad. Sci. USA 92:10990-10994.
182. 3. J. Steroid. Biochem. Mol. Biol. 103:435-439.
183. Zhang, J., M.J. Chalmers, K.R. Stayrook, L.L. Burris, Y. Wang, S.A. Busby, B.D. Pascal, R.D. Garcia-Ordonez, J.B. Bruning, M.A. Istrate et al. 2011. DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Natl. Struct. Mol. Biol. 18:556-563.
184. 3) 24-hydroxylase gene. Proc. Natl. Acad. Sci. USA 91:900-902.
185. 3) 24-hydroxylase gene. Proc. Natl. Acad. Sci. USA 91:900-902.
186. 3 receptor ablation alters mammary gland morphogenesis. Development 129:3067-3076.
187. 3 receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 23:2103-2109.
188. 3. J. Biol. Chem. 272:19027-19034.